WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that its scientists are scheduled to make several presentations at the 40th annual meeting of the Society for Neuroscience being held in San Diego, California from November 13 through November 17, 2010.
